General anesthesia with thoracic epidural anesthesia in the cardiopulmonary bypass surgery reduces apoptosis by upregulating antiapoptotic protein Bcl-2

Loading...
Publication Logo

Date

2006

Authors

Kılıçkan, Levent
Gonca, Süheyla
Dalcık, C.
Dalcık, H.
Solak, M.
Bayındır, Osman
Suezer, K.
Omay, O.
Kan, E. Cali

Journal Title

Journal ISSN

Volume Title

Publisher

Edizioni Minerva Medica

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

Research Projects

Journal Issue

Abstract

Aim. The aim of the paper was to investigate whether thoracic epidural anesthesia (TEA) together with general anaesthesia (GA) play a role on apoptosis in humans before cardiopulmonary bypass (CPB) before aortic cross clamp (ACC) and at 15 min after ACC release (after ischemia and reperfusion). Methods. Eighty patients scheduled for elective CABG were randomized to receive either GA group (n: 40) or TEA+GA group (n: 40). The right atrial biopsy samples were taken before CPB before ACC and at 15 min after ACC release from all patients. Human heart tissues were obtained from patients of TEA+GA group and GA group. The number of Bcl-2 positive cardiomyocytes was counted in multiple tissue sections of biopsies of 80 patients using fight microscopy (magnification X 40) with an ocular micrometer system (Olympus). Results. In the TEA+GA group the Bcl-2 positive cardiomyocytes were distinctly statistically increased compared to the GA group (P<0.001). in addition the intensity of the immunostaining was also increased in the TEA+GA compared with the GA group. The number of immunoreactive cardiomyocytes is as follows: before CPB TEA+GA group 396 61 GA group 92 41 before ACC TEA+GA group 333 47 GA group 94 18 at 15 min after ACC release TEA+GA group 346 +/- 68.8 GA group 85 +/- 9.5. There were statistically significant differences between groups (P<0.001). Between groups at 4 h and at 24 h after the end of CPB in the TEA+GA group the Cl was significantly higher than GA group respectively
(3.4 +/- 0.8 L/min/m(2) vs 2.5 +/- 0.8 L/min/m(2)
p<0.001) (3.8 +/- 1.1 L/min/m(2) vs 3.1 +/- 1.1 L/min/m(2)
P<0.008). Within groups at 4 and 24 h after the end of CPB in the TEA+GA group the Cl was significantly higher than baseline values respectively (3.4 +/- 0.8 L/min/m(2) vs 2.4 +/- 0.7 L/min/m(2)
P<0.001) (3.8 +/- 1.1 L/min/m(2) vs 2.4 +/- 0.7 L/min/m(2)
P<0.001). Whereas no difference was found in the GA group respectively (2.6 +/- 0.8 L/min/m(2) vs 2.5 +/- 0.8 L/min/m(2)
P>0.05) (2.6 +/- 0.8 L/min/m(2) vs 3.1 +/- 1.1 L/Min/m(2)
P>0.05). The number of patients showing ventricular fibrillation (VF) atrial fibrillation or heart block after release of the ACC was 11 of 40 (27.5%) in the TEA+GA group versus 25 of 40 (62.5%) in the GA group. The number of patients showing VF after release of ACC was 9 out of 20 patients (22.5%) in the TEA+GA group which was significantly lower than in the GA group (21 of 40 patients 52.5%)
(P<0.006). Sinus rhythm after release of ACC in the TEA+GA group was observed in 29 of 40 patients (72.5%) and was significantly higher than in the GA group (15 of 40 patients 37-5%)
(P<0.002). Conclusion The result of the present study indicate that TEA plus GA in coronary surgery had preserved cardiac function during intraoperative and postoperative period by means of reduced apoptosis improved hemodynamic function and reduced arrhythmias after release of the ACC.

Description

Keywords

Anesthesia epidural, Apoptosis, Bcl-2 gene, Myocardial protection, Coronary artery bypass grafting, Anesthesia, Epidural, Male, Cardiopulmonary Bypass, Apoptosis, Cell Count, Coronary Artery Disease, Anesthesia, General, Middle Aged, Surgical Instruments, Combined Modality Therapy, Immunohistochemistry, Up-Regulation, Heart Block, Treatment Outcome, Proto-Oncogene Proteins c-bcl-2, Atrial Fibrillation, Humans, Female, Myocytes, Cardiac, Aged, Coronary artery bypass grafting, Myocardial protection, Bcl-2 gene, Anesthesia epidural

Fields of Science

03 medical and health sciences, 0302 clinical medicine

Citation

WoS Q

Q3

Scopus Q

Q2
OpenCitations Logo
OpenCitations Citation Count
12

Source

The Journal of cardiovascular surgery

Volume

47

Issue

3

Start Page

315

End Page

322
PlumX Metrics
Citations

Scopus : 18

PubMed : 2

Captures

Mendeley Readers : 23

SCOPUS™ Citations

19

checked on Feb 17, 2026

Web of Science™ Citations

17

checked on Feb 17, 2026

Page Views

1

checked on Feb 17, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.38165526

Sustainable Development Goals

SDG data is not available